GGrantIndex
Sort

51,570 grants matching autoimmune disease

HVEM-BTLA system in Inflammation

$480,000
Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · AI

Regulation of TH17 Cell Development and Function by the REV-ERBs

$480,000
Laura A Solt · Scripps Florida · R01 · FY2020 · AI

HVEM-BTLA system in Inflammation

$480,000
Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · AI

Therapeutic effects of histone deacetylase inhibitors on FOXP3 Treg functions

$479,955
Wayne William Hancock · University Of Pennsylvania · P01 · FY2011 · AI

The Role of EBI3 in Regulating Gastritis and Gastric Carcinogenesis

$479,906
Richard J Dipaolo · Saint Louis University · R01 · FY2016 · DK

Viruses and Autoimmunity

$479,822
La Jolla Inst For Allergy &Immunolgy · P01 · FY2005 · AI

Protein O-GlcNAcylation in Regulatory T Cell Function

$479,721
Hai-Bin Ruan · University Of Minnesota · R01 · FY2022 · AI

Protein O-GlcNAcylation in Regulatory T Cell Function

$479,721
Hai-Bin Ruan · University Of Minnesota · R01 · FY2021 · AI

Protein O-GlcNAcylation in Regulatory T Cell Function

$479,721
Hai-Bin Ruan · University Of Minnesota · R01 · FY2023 · AI

A Novel Tolerance Therapeutic for Treating Multiple Sclerosis

$479,708
Neil A Fanger · Virtici, Llc · R44 · FY2016 · AI

Continuation of UCSF as a Clinical Center for TrialNet

$479,692
Stephen E Gitelman · University Of California, San Francisco · U01 · FY2017 · DK

Continuation of UCSF as a Clinical Center for TrialNet

$479,692
Stephen E Gitelman · University Of California, San Francisco · U01 · FY2015 · DK

Continuation of UCSF as a Clinical Center for TrialNet

$479,692
Stephen E Gitelman · University Of California, San Francisco · U01 · FY2016 · DK

GENETIC BASIS OF SYSTEMIC AUTOIMMUNITY

$479,631
Scripps Research Institute · R01 · FY2002 · AR

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

$479,619
William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2015 · CA

Pathogenesis of Behcet's disease and Still's disease

$479,587
Raphaela Goldbach-Mansky · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2011 · AR

Reprogramming committed blood cells to a hematopoietic stem cell fate

$479,492
Derrick J. Rossi · Boston Children'S Hospital · R01 · FY2013 · HL

Regulation of R-loop Formation and Genome Stability by ADAR1

$479,470
Kazuko Nishikura · Wistar Institute · R01 · FY2021 · GM

Regulation of R-loop Formation and Genome Stability by ADAR1

$479,470
Kazuko Nishikura · Wistar Institute · R01 · FY2019 · GM

Regulation of R-loop Formation and Genome Stability by ADAR1

$479,470
Kazuko Nishikura · Wistar Institute · R01 · FY2020 · GM

Regulation of R-loop Formation and Genome Stability by ADAR1

$479,470
Kazuko Nishikura · Wistar Institute · R01 · FY2018 · GM

Defining the influence of RA genetic susceptibility factors on T cell antigen specificity and functional state

$479,437
Soumya Raychaudhuri · Brigham And Women'S Hospital · R01 · FY2024 · AR

Engineering Functional Salivary Glands Using Micropatterned Scaffolds

$479,435
Melinda Larsen · State University Of New York At Albany · R01 · FY2015 · DE

Gliovascular Mechanisms of Blood-Brain Barrier Disruption in Neuroinflammatory Disease

$479,425
Dimitrios Davalos · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · NS

Gliovascular Mechanisms of Blood-Brain Barrier Disruption in Neuroinflammatory Disease

$479,424
Dimitrios Davalos · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS